Washington: Clinical trials have been started in the US for the treatment of patients with mild and moderately infected with Covid. The NIH said on Tuesday that a Phase II trial has been released in the US to evaluate a potential therapeutic safety and efficacy for Covid. This clinical trial includes a clinical trial based on mAbs for the treatment of Covid-19.
In parts of NIH, US NIAID-sponsored researchers are working with clinical sites. He is working on potential volunteers who are currently infected with Covid. According to an NIH release, mild to moderate corona patients do not need to be admitted to the hospital for treatment.
Mild and moderate Covid-infected patients are invited to seek medical therapy or a placebo, which may occur as part of a rigorously designed clinical. This test is known as ACTIV-2. Other experimental treatments can also be investigated later under the same test protocol.